alphaVbeta8-IN-1 is a alphaVbeta8 integrin inhibitor. alphaVbeta8-IN-1 has been shown to inhibit the growth of tumors such as EMT6, CT26, KPC, and TKCC-10. alphaVbeta8-IN-1 can be used in research related to idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP), and tumors[1].
Molecular Weight:
502.01
Purity:
96.31
CAS Number:
[3048440-55-4]
Formula:
C25H32ClN5O4
Target:
Integrin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted